These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6139021)

  • 1. Effect of outpatient treatment of asthma with beta agonists on the response to sympathomimetics in an emergency room.
    Rossing TH; Fanta CH; McFadden ER
    Am J Med; 1983 Nov; 75(5):781-4. PubMed ID: 6139021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sympathomimetics for acute severe asthma: should only beta 2-selective agonists be used?
    Reed MT; Kelly HW
    DICP; 1990 Sep; 24(9):868-73. PubMed ID: 1979708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of beta-adrenergic agonists.
    McFadden ER
    J Allergy Clin Immunol; 1985 Aug; 76(2 Pt 2):352-6. PubMed ID: 2862175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled beta 2-adrenoceptor agonists in asthma: help or hindrance?
    Lipworth BJ; McDevitt DG
    Br J Clin Pharmacol; 1992 Feb; 33(2):129-38. PubMed ID: 1347999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and long-term tolerance of beta-2 adrenergic stimulants].
    Zellweger JP
    Schweiz Rundsch Med Prax; 1990 May; 79(22):691-3. PubMed ID: 1971961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early bronchodilating effect of a new oral beta-2-receptor agonist (broxaterol) in bronchial asthma.
    Chetta A; Garavaldi G; Cuomo A; Gurrieri G; Olivieri D
    Respiration; 1988; 53(4):220-4. PubMed ID: 2902671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the bronchodilating effects of five beta-adrenergic stimulants administered by inhalation to patients with bronchial asthma].
    Kokubu H
    Arerugi; 1993 Jun; 42(6):699-705. PubMed ID: 8102230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
    Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
    Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salmeterol: a long-acting beta 2-agonist.
    D'Alonzo GE; Tolep K
    J Am Osteopath Assoc; 1998 Apr; 98(4):216-8, 221-31. PubMed ID: 9594486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronopharmacology of reversible airway obstruction].
    Haen E
    Wien Med Wochenschr; 1995; 145(17-18):439-45. PubMed ID: 8588360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthma.
    Bijl-Hofland ID; Cloosterman SG; Folgering HT; van den Elshout FJ; van Weel C; van Schayck CP
    Am J Respir Crit Care Med; 2001 Sep; 164(5):764-9. PubMed ID: 11549530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the efficacy of nebulized salbutamol in exacerbation of chronic asthma].
    Mincewicz G; Sopel R; Kozłowki M; Kurowski W
    Pneumonol Alergol Pol; 1997; 65(11-12):788-92. PubMed ID: 9760793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Asthma therapy: are bronchodilators obsolete?].
    Solèr M
    Schweiz Med Wochenschr; 1992 Mar; 122(13):455-60. PubMed ID: 1348869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting beta-agonist treatment in patients with persistent asthma already receiving inhaled corticosteroids.
    Hancox RJ; Taylor DR
    BioDrugs; 2001; 15(1):11-24. PubMed ID: 11437672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
    Rowe BH; Wong E; Blitz S; Diner B; Mackey D; Ross S; Senthilselvan A
    Acad Emerg Med; 2007 Oct; 14(10):833-40. PubMed ID: 17898245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of IV beta-agonists in treating patients with acute asthma in the emergency department: a meta-analysis.
    Travers AH; Rowe BH; Barker S; Jones A; Camargo CA
    Chest; 2002 Oct; 122(4):1200-7. PubMed ID: 12377842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use in special patient groups: beta-sympathomimetics in children and pregnant women].
    Klein MO; Hilpert F; Ankermann T
    Pharm Unserer Zeit; 2011 Sep; 40(5):417-21. PubMed ID: 22299160
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential for tolerance, morbidity, and mortality resulting from regular use of beta 2-adrenergic agonists in asthma.
    Giangrasso T
    South Med J; 1997 Feb; 90(2):173-9. PubMed ID: 9042167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
    Sovani MP; Whale CI; Tattersfield AE
    Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient management of bronchial asthma in adults.
    Rosa JD; Chandy D; Aronow WS; DeLorenzo LJ
    Compr Ther; 2008; 34(1):10-7. PubMed ID: 18681106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.